Propofol Use in Pediatric Sedations: Will a Lesser Dose be Effective? A Quality Improvement Project

Mir H Ali1,2, Michael Vlach3, Ethan Leif3

  • 1Sanford Children's Specialty Clinic, Sioux Falls, South Dakota.

Insights

A new protocol using a lower propofol drip rate (175-199 mcg/kg/min) achieved successful pediatric sedation for MRIs, reducing medication dosage while maintaining imaging quality.

Area of Science:

  • Anesthesiology
  • Pediatric Imaging
  • Pharmacology

Background:

  • Propofol is crucial for pediatric MRI sedation, enabling patient immobility and high-quality imaging.
  • Sanford Children's currently lacks a standardized propofol sedation protocol for pediatric MRI procedures.
  • Optimizing propofol dosage is essential to balance sedation efficacy and patient safety.

Purpose of the Study:

  • To evaluate the feasibility of decreasing propofol dosage for pediatric MRI sedation.
  • To establish a standard protocol for propofol administration in pediatric MRI.

Main Methods:

  • A three-phase retrospective chart review was conducted.
  • Phase 1: Reviewed existing propofol dosing (6 months).
  • Phase 2: Implemented target drip dose of 200-300 mcg/kg/min (6 months).
  • Phase 3: Implemented target drip dose of 175-200 mcg/kg/min (4 months).
  • Sedation success was defined as completing the MRI without patient awakening.

Main Results:

  • 181 pediatric patients (6 months-16 years) were included.
  • Successful sedation rates were 83% in Phase 2 and 84% in Phase 3.
  • Average total propofol dose decreased from 15.43 mg/kg (Phase 1) to 12.31 mg/kg (Phase 3).
  • Mean arterial pressure (MAP) was below normal in 60% of all sedations.

Conclusions:

  • A protocol with a propofol drip rate of 175-199 mcg/kg/min ensures successful pediatric sedation for MRIs.
  • This optimized dosage prevents excessive propofol administration.
  • Further research into MAP trends during sedation is warranted.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
175
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
394
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
259
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
543
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
358
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
213